mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.06 |
0.7 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |